Cytogenetically cryptic AML1-ETO and CBFβ-MYH11 gene rearrangements: incidence in 412 cases of acute myeloid leukaemia
Authors:
- 1 December 2000
- journal article
- Published by Wiley in British Journal of Haematology
- Vol. 111 (4) , 1051-1056
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- TrueLeukemia, 1999
- Detection of karyotypic aberrations in acute myeloblastic leukaemia: a prospective comparison between PCR/FISH and standard cytogenetics in 140 patients with de novo AMLBritish Journal of Haematology, 1998
- The Importance of Diagnostic Cytogenetics on Outcome in AML: Analysis of 1,612 Patients Entered Into the MRC AML 10 TrialBlood, 1998
- Incidence of AML1/ETO fusion transcripts in patients entered into the MRC AML trialsBritish Journal of Haematology, 1997
- Molecular detection of t(8;21)/AML1‐ETO in AML M1/M2: correlation with cytogenetics, morphology and immunophenotypeBritish Journal of Haematology, 1996
- Junctions of the AML1/MTG8(ETO) fusion are constant in t(8;21) acute myeloid leukemia detected by reverse transcription polymerase chain reactionBlood, 1993
- Proposal for the recognition of minimally differentiated acute myeloid leukaemia (AML‐MO)British Journal of Haematology, 1991
- Avoiding false positives with PCRNature, 1989
- Proposed Revised Criteria for the Classification of Acute Myeloid LeukemiaAnnals of Internal Medicine, 1985
- Criteria for the Diagnosis of Acute Leukemia of Megakaryocyte Lineage (M7)Annals of Internal Medicine, 1985